173 related articles for article (PubMed ID: 17270373)
1. Effect of fiber length of carbon nanotubes on the absorption of erythropoietin from rat small intestine.
Ito Y; Venkatesan N; Hirako N; Sugioka N; Takada K
Int J Pharm; 2007 Jun; 337(1-2):357-60. PubMed ID: 17270373
[TBL] [Abstract][Full Text] [Related]
2. Liquid filled nanoparticles as a drug delivery tool for protein therapeutics.
Venkatesan N; Yoshimitsu J; Ito Y; Shibata N; Takada K
Biomaterials; 2005 Dec; 26(34):7154-63. PubMed ID: 15967493
[TBL] [Abstract][Full Text] [Related]
3. Gastro-intestinal patch system for the delivery of erythropoietin.
Venkatesan N; Uchino K; Amagase K; Ito Y; Shibata N; Takada K
J Control Release; 2006 Mar; 111(1-2):19-26. PubMed ID: 16377018
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic and pharmacodynamic studies following oral administration of erythropoietin mucoadhesive tablets to beagle dogs.
Venkatesan N; Yoshimitsu J; Ohashi Y; Ito Y; Sugioka N; Shibata N; Takada K
Int J Pharm; 2006 Mar; 310(1-2):46-52. PubMed ID: 16439074
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic and pharmacodynamic studies following percutaneous absorption of erythropoietin micropiles to rats.
Ito Y; Shiroyama K; Yoshimitsu J; Ohashi Y; Sugioka N; Takada K
J Control Release; 2007 Aug; 121(3):176-80. PubMed ID: 17628163
[TBL] [Abstract][Full Text] [Related]
6. Effect of adsorbents on the absorption of lansoprazole with surfactant.
Ito Y; Arai H; Uchino K; Iwasaki K; Shibata N; Takada K
Int J Pharm; 2005 Jan; 289(1-2):69-77. PubMed ID: 15652200
[TBL] [Abstract][Full Text] [Related]
7. Carbon nanotubes as functional excipients for nanomedicines: II. Drug delivery and biocompatibility issues.
Foldvari M; Bagonluri M
Nanomedicine; 2008 Sep; 4(3):183-200. PubMed ID: 18550450
[TBL] [Abstract][Full Text] [Related]
8. Oral solid gentamicin preparation using emulsifier and adsorbent.
Ito Y; Kusawake T; Ishida M; Tawa R; Shibata N; Takada K
J Control Release; 2005 Jun; 105(1-2):23-31. PubMed ID: 15908031
[TBL] [Abstract][Full Text] [Related]
9. Preparation and evaluation of oral solid heparin using emulsifier and adsorbent for in vitro and in vivo studies.
Ito Y; Kusawake T; Prasad YV; Sugioka N; Shibata N; Takada K
Int J Pharm; 2006 Jul; 317(2):114-9. PubMed ID: 16631328
[TBL] [Abstract][Full Text] [Related]
10. Self-dissolving micropile array chip as percutaneous delivery system of protein drug.
Ito Y; Hasegawa R; Fukushima K; Sugioka N; Takada K
Biol Pharm Bull; 2010; 33(4):683-90. PubMed ID: 20410606
[TBL] [Abstract][Full Text] [Related]
11. Enhancing effect of Labrafac Lipophile WL 1349 on oral bioavailability of hydroxysafflor yellow A in rats.
Wang S; Sun M; Ping Q
Int J Pharm; 2008 Jun; 358(1-2):198-204. PubMed ID: 18417306
[TBL] [Abstract][Full Text] [Related]
12. Erythropoietin-coated ZP-microneedle transdermal system: preclinical formulation, stability, and delivery.
Peters EE; Ameri M; Wang X; Maa YF; Daddona PE
Pharm Res; 2012 Jun; 29(6):1618-26. PubMed ID: 22258935
[TBL] [Abstract][Full Text] [Related]
13. Erythropoietin-loaded oligochitosan nanoparticles for treatment of periventricular leukomalacia.
Wang T; Hu Y; Leach MK; Zhang L; Yang W; Jiang L; Feng ZQ; He N
Int J Pharm; 2012 Jan; 422(1-2):462-71. PubMed ID: 22101293
[TBL] [Abstract][Full Text] [Related]
14. Carbon nanotubes as functional excipients for nanomedicines: I. Pharmaceutical properties.
Foldvari M; Bagonluri M
Nanomedicine; 2008 Sep; 4(3):173-82. PubMed ID: 18550451
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease.
Smith WB; Dowell JA; Pratt RD
Clin Ther; 2007 Jul; 29(7):1368-80. PubMed ID: 17825688
[TBL] [Abstract][Full Text] [Related]
16. Absorption of interferon alpha from patches in rats.
Ito Y; Tosh B; Togashi Y; Amagase K; Kishida T; Kishida T; Sugioka N; Shibata N; Takada K
J Drug Target; 2005 Jul; 13(6):383-90. PubMed ID: 16278158
[TBL] [Abstract][Full Text] [Related]
17. Semi-mechanistic Pharmacokinetic/Pharmacodynamic model of three pegylated rHuEPO and ior®EPOCIM in New Zealand rabbits.
Reynaldo-Fernández G; Solozábal J; Amaro D; Fernández-Sánchez EM; Rodríguez-Vera L; Bermejo M; Mangas-Sanjuan V; Troconiz IF
Eur J Pharm Sci; 2018 Jul; 120():123-132. PubMed ID: 29729414
[TBL] [Abstract][Full Text] [Related]
18. [Progress in the research of carbon nanotubes as drug carriers].
Yu JG; Huang KL; Yang QQ; Liu SQ; Tang JC
Yao Xue Xue Bao; 2008 Oct; 43(10):985-91. PubMed ID: 19127860
[TBL] [Abstract][Full Text] [Related]
19. Functionalized carbon nanotubes in drug design and discovery.
Prato M; Kostarelos K; Bianco A
Acc Chem Res; 2008 Jan; 41(1):60-8. PubMed ID: 17867649
[TBL] [Abstract][Full Text] [Related]
20. Influence of length on cytotoxicity of multi-walled carbon nanotubes against human acute monocytic leukemia cell line THP-1 in vitro and subcutaneous tissue of rats in vivo.
Sato Y; Yokoyama A; Shibata K; Akimoto Y; Ogino S; Nodasaka Y; Kohgo T; Tamura K; Akasaka T; Uo M; Motomiya K; Jeyadevan B; Ishiguro M; Hatakeyama R; Watari F; Tohji K
Mol Biosyst; 2005 Jul; 1(2):176-82. PubMed ID: 16880981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
